德邁仕(301007.SZ):擬使用不超1億元閒置自有資金購買理財產品
格隆匯7月2日丨德邁仕(301007.SZ)公佈,公司於2021年7月1日召開第二屆董事會第二十九次會議和第二屆監事會第十四次會議,審議通過了《關於使用自有閒置資金購買理財產品的議案》,同意公司在不影響正常運營資金使用的情況下,使用額度合計不超過人民幣1億元的閒置自有資金用於購買安全性高、流動性好、低風險的理財產品,使用期限自本次董事會審議並通過之日起12個月內有效。
在上述使用期限及額度範圍內,公司可循環滾動購買理財產品,同時授權董事長或董事長授權人員在額度範圍內行使該項投資決策權及簽署相關合同文件等事宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.